Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             251 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Abdominal epilepsy Zinkin, Noah T.
2005
38-39 2 p. 263-274
12 p.
artikel
2 Acquired causes of intestinal malabsorption van der Heide, F.
2016
38-39 2 p. 213-224
12 p.
artikel
3 Acute intermittent porphyria Herrick, Ariane L.
2005
38-39 2 p. 235-249
15 p.
artikel
4 Acute kidney injury after liver transplantation: Recent insights and future perspectives de Haan, Jubi E.
2017
38-39 2 p. 161-169
9 p.
artikel
5 Acute variceal bleeding: Pharmacological treatment and primary/secondary prophylaxis Dell'Era, A.
2008
38-39 2 p. 279-294
16 p.
artikel
6 Adjuvant chemotherapy for colon cancer Ducreux, M.
2002
38-39 2 p. 283-298
16 p.
artikel
7 Advanced precancerous lesions (APL) in the colonic mucosa Naini, Bita V.
2013
38-39 2 p. 235-256
22 p.
artikel
8 Advanced precancerous lesions in the liver Di Tommaso, Luca
2013
38-39 2 p. 269-284
16 p.
artikel
9 Advanced precancerous lesions in the lower oesophageal mucosa: High-grade dysplasia and intramucosal carcinoma in Barrett's oesophagus Coron, Emmanuel
2013
38-39 2 p. 187-204
18 p.
artikel
10 Advanced precancerous lesions in the small bowel mucosa Genta, Robert M.
2013
38-39 2 p. 225-233
9 p.
artikel
11 Advanced precancerous lesions within the GI tract: The molecular background Fassan, Matteo
2013
38-39 2 p. 159-169
11 p.
artikel
12 Advantages and disadvantages of population screening for cancer and surveillance of at-risk groups Craanen, Mikael E.
2001
38-39 2 p. 211-226
16 p.
artikel
13 Adverse effects of biologics used for treating IBD Stallmach, Andreas
2010
38-39 2 p. 167-182
16 p.
artikel
14 Adverse effects of drugs in the treatment of viral hepatitis Negro, Francesco
2010
38-39 2 p. 183-192
10 p.
artikel
15 Adverse effects of drugs on small intestine and colon Zeino, Zeino
2010
38-39 2 p. 133-141
9 p.
artikel
16 Adverse effects of drugs on the esophagus Tutuian, Radu
2010
38-39 2 p. 91-97
7 p.
artikel
17 Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract Sostres, Carlos
2010
38-39 2 p. 121-132
12 p.
artikel
18 Adverse effects of proton pump inhibitors Lodato, Francesca
2010
38-39 2 p. 193-201
9 p.
artikel
19 A historical perspective of Helicobacter gastroduodenitis and its complications Egan, Brian J.
2007
38-39 2 p. 335-346
12 p.
artikel
20 Aims & Scope/Editorial Board 2009
38-39 2 p. iii-
1 p.
artikel
21 Aims & scope/editorial board 2008
38-39 2 p. iii-
1 p.
artikel
22 Aims & scope/editorial board 2006
38-39 2 p. iii-
1 p.
artikel
23 Aims & scope/editorial board 2007
38-39 2 p. iii-
1 p.
artikel
24 Aims & Scope/ Editorial Board 2010
38-39 2 p. iii-
1 p.
artikel
25 Aims ; scope/editorial board 2005
38-39 2 p. iii-
1 p.
artikel
26 Aims & Scope/ Editorial Board 2015
38-39 2 p. iii-
1 p.
artikel
27 Aims & Scope/ Editorial Board 2017
38-39 2 p. iii-
1 p.
artikel
28 Aims & Scope/ Editorial Board 2011
38-39 2 p. iii-
1 p.
artikel
29 Aims & Scope/ Editorial Board 2016
38-39 2 p. iii-
1 p.
artikel
30 Aims & Scope/ Editorial Board 2013
38-39 2 p. iii-
1 p.
artikel
31 Aims & Scope/ Editorial Board 2012
38-39 2 p. iii-
1 p.
artikel
32 Aims & Scope/ Editorial Board 2014
38-39 2 p. iii-
1 p.
artikel
33 Alcohol use and smoking after liver transplantation; complications and prevention Ursic-Bedoya, José
2017
38-39 2 p. 181-185
5 p.
artikel
34 Animal models for the study of hepatic fibrosis Starkel, Peter
2011
38-39 2 p. 319-333
15 p.
artikel
35 Antibiotic-associated diarrhoea Beaugerie, Laurent
2004
38-39 2 p. 337-352
16 p.
artikel
36 Anti-fibrogenic strategies and the regression of fibrosis Kisseleva, Tatiana
2011
38-39 2 p. 305-317
13 p.
artikel
37 Antimicrobial prophylaxis in acute pancreatitis: selective decontamination versus antibiotics Luiten, Ernest J.T.
1999
38-39 2 p. 317-330
14 p.
artikel
38 Artificial nutrition at the end of life: Ethical issues van de Vathorst, Suzanne
2014
38-39 2 p. 247-253
7 p.
artikel
39 Aspirin and NSAIDs; benefits and harms for the gut Thiagarajan, Prarthana
2012
38-39 2 p. 197-206
10 p.
artikel
40 Aspirin and the prevention of colorectal cancer Ferrández, Ángel
2012
38-39 2 p. 185-195
11 p.
artikel
41 Aspirin: The balance between benefits and harms Lanas, Angel
2012
38-39 2 p. 97-99
3 p.
artikel
42 Assessment of growth and nutrition Gokhale, Ranjana
2003
38-39 2 p. 153-162
10 p.
artikel
43 Assessment of intestinal malabsorption Nikaki, K.
2016
38-39 2 p. 225-235
11 p.
artikel
44 Autoimmune hepatitis Strassburg, Christian P
2003
38-39 2 p. 291-306
16 p.
artikel
45 Balancing the risk and benefits of low-dose aspirin in clinical practice Casado-Arroyo, Rubén
2012
38-39 2 p. 173-184
12 p.
artikel
46 Biliary complications after liver transplantation; recent developments in etiology, diagnosis and endoscopic treatment Roos, Floris J.M.
2017
38-39 2 p. 227-235
9 p.
artikel
47 Bugs and the gut: an unstable marriage Farthing, Michael J.G
2004
38-39 2 p. 233-239
7 p.
artikel
48 Changing concepts in the surgical management of acute pancreatitis Gloor, Beat
1999
38-39 2 p. 303-315
13 p.
artikel
49 Chemotherapy for advanced pancreatic cancer Chua, Yu Jo
2006
38-39 2 p. 327-348
22 p.
artikel
50 Cholangiocarcinoma Vogel, Arndt
2015
38-39 2 p. 219-
1 p.
artikel
51 Chronic mesenteric ischemia Sreenarasimhaiah, Jayaprakash
2005
38-39 2 p. 283-295
13 p.
artikel
52 Chronic viral hepatitis Marcellin, Patrick
2003
38-39 2 p. 259-275
17 p.
artikel
53 Clinical presentation, risk factors and staging systems of cholangiocarcinoma Plentz, Ruben R.
2015
38-39 2 p. 245-252
8 p.
artikel
54 Coeliac disease Ciclitira, Paul J
2003
38-39 2 p. 181-195
15 p.
artikel
55 Colonic screening and surveillance Kronborg, Ole
2001
38-39 2 p. 301-316
16 p.
artikel
56 Competence assessment in minors, illustrated by the case of bariatric surgery for morbidly obese children Bolt, Ineke L.L.E.
2014
38-39 2 p. 293-302
10 p.
artikel
57 Complex management issues: management of HCV in the atypical patient Hadziyannis, Stephanos J
2000
38-39 2 p. 277-291
15 p.
artikel
58 Congenital intestinal diarrhoeal diseases: A diagnostic and therapeutic challenge Posovszky, C.
2016
38-39 2 p. 187-211
25 p.
artikel
59 Current endoscopic and pharmacological therapy of peptic ulcer bleeding Aabakken, Lars
2008
38-39 2 p. 243-259
17 p.
artikel
60 Current endoscopic therapy of variceal bleeding Villanueva, Càndid
2008
38-39 2 p. 261-278
18 p.
artikel
61 Cystic fibrosis Jackson, Reuben
2003
38-39 2 p. 213-235
23 p.
artikel
62 Cytokines and acute pancreatitis Brady, Mark
1999
38-39 2 p. 265-289
25 p.
artikel
63 Defensin-mediated innate immunity in the small intestine Ouellette, Andre J
2004
38-39 2 p. 405-419
15 p.
artikel
64 Deficiencies of C1 inhibitor Rosen, Fred S.
2005
38-39 2 p. 251-261
11 p.
artikel
65 Definitions of intestinal failure and the short bowel syndrome Pironi, Loris
2016
38-39 2 p. 173-185
13 p.
artikel
66 Diabetic thoracic polyradiculopathy Longstreth, George F.
2005
38-39 2 p. 275-281
7 p.
artikel
67 Diagnosis of Helicobacter pylori: Invasive and non-invasive tests Ricci, Chiara
2007
38-39 2 p. 299-313
15 p.
artikel
68 Drug induced pancreatitis Nitsche, Claudia J.
2010
38-39 2 p. 143-155
13 p.
artikel
69 Dyspepsia as an adverse effect of drugs Bytzer, Peter
2010
38-39 2 p. 109-120
12 p.
artikel
70 Early events in acute pancreatitis Steer, Michael L.
1999
38-39 2 p. 213-225
13 p.
artikel
71 Editorial Board 2003
38-39 2 p. iii-
1 p.
artikel
72 Editorial Board 2004
38-39 2 p. iii-
1 p.
artikel
73 Efficacy and gastrointestinal risk of aspirin used for the treatment of pain and cold McCarthy, Denis M.
2012
38-39 2 p. 101-112
12 p.
artikel
74 Endoscopic diagnosis of cholangiocarcinoma: From endoscopic retrograde cholangiography to bile proteomics Voigtländer, Torsten
2015
38-39 2 p. 267-275
9 p.
artikel
75 Enteral approaches in malabsorption Avitzur, Yaron
2016
38-39 2 p. 295-307
13 p.
artikel
76 Enteral versus parenteral nutrition in acute pancreatitis Guillou, P.J.
1999
38-39 2 p. 345-355
11 p.
artikel
77 Eosinophilic gastroenteritis Khan, Seema
2005
38-39 2 p. 177-198
22 p.
artikel
78 Epidemiology and risk factors for pancreatic cancer Lowenfels, Albert B.
2006
38-39 2 p. 197-209
13 p.
artikel
79 Epidemiology and screening of colorectal cancer Faivre, Jean
2002
38-39 2 p. 187-199
13 p.
artikel
80 Epidemiology of acute upper gastrointestinal bleeding van Leerdam, M.E.
2008
38-39 2 p. 209-224
16 p.
artikel
81 Epidemiology of cholangiocarcinoma Bergquist, Annika
2015
38-39 2 p. 221-232
12 p.
artikel
82 Epidemiology of Helicobacter pylori infection Malaty, Hoda M.
2007
38-39 2 p. 205-214
10 p.
artikel
83 Epidemiology of lower gastrointestinal bleeding Zuccaro, Gregory
2008
38-39 2 p. 225-232
8 p.
artikel
84 Epithelial cell responses R. Mahida, Y
2004
38-39 2 p. 241-253
13 p.
artikel
85 Epithelial cell responses Mavris, Maria
2004
38-39 2 p. 373-386
14 p.
artikel
86 Erratum to “The pathology of diverticular disease” [Best Practice and Research Clinical Gastroenterology 16 (2002) 543–562] Ludeman, Linmarie
2003
38-39 2 p. 323-324
2 p.
artikel
87 Esophageal squamous cell carcinoma with special reference to its early stage Shimizu, Michio
2013
38-39 2 p. 171-186
16 p.
artikel
88 Ethical aspects of obesity prevention ten Have, Marieke
2014
38-39 2 p. 303-314
12 p.
artikel
89 Ethical issues in colorectal cancer screening van Dam, Leonie
2014
38-39 2 p. 315-326
12 p.
artikel
90 Ethical issues raised by whole genome sequencing Pinxten, Wim
2014
38-39 2 p. 269-279
11 p.
artikel
91 Everything you always wanted to know about Ethical issues in gastroenterology... de Beaufort, Inez
2014
38-39 2 p. 233-234
2 p.
artikel
92 Evidence-based diagnosis and staging of pancreatic cancer Michl, Patrick
2006
38-39 2 p. 227-251
25 p.
artikel
93 Expensive cancer drugs and just health care Ehni, Hans-Jörg
2014
38-39 2 p. 327-337
11 p.
artikel
94 Familial adenomatous polyposis Macrae, Finlay
2009
38-39 2 p. 197-207
11 p.
artikel
95 Familial Mediterranean fever—a not so unusual cause of abdominal pain Simon, Anna
2005
38-39 2 p. 199-213
15 p.
artikel
96 Fibrosis in alcoholic and nonalcoholic steatohepatitis Bataller, Ramon
2011
38-39 2 p. 231-244
14 p.
artikel
97 Fibrosis in Autoimmune and Cholestatic Liver Disease Penz-Österreicher, Melitta
2011
38-39 2 p. 245-258
14 p.
artikel
98 Fibrosis in chronic viral hepatitis Calvaruso, Vincenza
2011
38-39 2 p. 219-230
12 p.
artikel
99 Foreword to liver fibrosis Pinzani, Massimo
2011
38-39 2 p. 193-194
2 p.
artikel
100 From organoids to organs: Bioengineering liver grafts from hepatic stem cells and matrix Willemse, Jorke
2017
38-39 2 p. 151-159
9 p.
artikel
101 Future directions in the treatment of cholangiocarcinoma Zhu, Andrew X.
2015
38-39 2 p. 355-361
7 p.
artikel
102 Future expectations in the prophylaxis of intestinal bleeding Klebl, F.H.
2008
38-39 2 p. 373-387
15 p.
artikel
103 Gastrointestinal and liver adverse effects of drugs used for treating IBD Rogler, Gerhard
2010
38-39 2 p. 157-165
9 p.
artikel
104 Gastrointestinal and liver side effects of drugs in elderly patients Triantafyllou, Konstantinos
2010
38-39 2 p. 203-215
13 p.
artikel
105 Gastrointestinal cancer Heavey, Patricia M
2004
38-39 2 p. 323-336
14 p.
artikel
106 Gastrointestinal lesions and complications of low-dose aspirin in the gastrointestinal tract Sostres, Carlos
2012
38-39 2 p. 141-151
11 p.
artikel
107 Gastrointestinal lymphoma: prevention and treatment of early lesions Ruskoné-Fourmestraux, Agnès
2001
38-39 2 p. 337-354
18 p.
artikel
108 Gastro-oesophageal reflux disease and motility disorders Salvatore, Sylvia
2003
38-39 2 p. 163-179
17 p.
artikel
109 Gene therapy developments for pancreatic cancer Bhattacharyya, Madhumita
2006
38-39 2 p. 285-298
14 p.
artikel
110 Genetic counselling and genetic testing in hereditary gastrointestinal cancer syndromes Raymond, Victoria M.
2009
38-39 2 p. 275-283
9 p.
artikel
111 Genetics and epigenetics in the fibrogenic evolution of chronic liver diseases Zimmer, Vincent
2011
38-39 2 p. 269-280
12 p.
artikel
112 Genetic testing in gastroenterology: Lynch syndrome Grover, Shilpa
2009
38-39 2 p. 185-196
12 p.
artikel
113 Genetic testing in other GI diseases Hodgson, Shirley
2009
38-39 2 p. 245-256
12 p.
artikel
114 Gut microflora in the pathogenesis of the complications of cirrhosis Garcia-Tsao, Guadalupe
2004
38-39 2 p. 353-372
20 p.
artikel
115 Hamartomatous polyposis syndromes Gammon, Amanda
2009
38-39 2 p. 219-231
13 p.
artikel
116 HCV: epidemiology, modes of transmission and prevention of spread Pradat, P
2000
38-39 2 p. 201-210
10 p.
artikel
117 HCV genotypes—role in pathogenesis of disease and response to therapy Webster, George
2000
38-39 2 p. 229-240
12 p.
artikel
118 Helicobacter pylori and benign upper digestive disease Lai, Larry H.
2007
38-39 2 p. 261-279
19 p.
artikel
119 Helicobacter pylori and extragastric diseases Franceschi, Francesco
2007
38-39 2 p. 325-334
10 p.
artikel
120 Helicobacter pylori infection and gastric cancer Lochhead, Paul
2007
38-39 2 p. 281-297
17 p.
artikel
121 Hepatitis C virus infection: co-infection with HIV and HBV Cropley, Ian
2000
38-39 2 p. 265-275
11 p.
artikel
122 Hepatitis E virus: A potential threat for patients with liver disease and liver transplantation van der Eijk, Annemiek A.
2017
38-39 2 p. 143-150
8 p.
artikel
123 Hepatocellular carcinoma in patients with HCV Colombo, Massimo
2000
38-39 2 p. 327-339
13 p.
artikel
124 Hereditary gastric cancer Oliveira, Carla
2009
38-39 2 p. 147-157
11 p.
artikel
125 Hereditary haemochromatosis Janssen, M.C.H.
2009
38-39 2 p. 171-183
13 p.
artikel
126 Hereditary pancreatic cancer: A clinical perspective Greer, Julia B.
2009
38-39 2 p. 159-170
12 p.
artikel
127 Hereditary pancreatitis: new insights, new directions Whitcomb, David C.
1999
38-39 2 p. 253-263
11 p.
artikel
128 Hereditary polyposis syndromes and hereditary non-polyposis colorectal cancer Allen, Brian A
2003
38-39 2 p. 237-258
22 p.
artikel
129 Human stem-cell research in gastroenterology: Experimental treatment, tourism and biobanking Hermerén, Göran
2014
38-39 2 p. 257-268
12 p.
artikel
130 Hypo- and normothermic perfusion of the liver: Which way to go? Selten, Jasmijn
2017
38-39 2 p. 171-179
9 p.
artikel
131 Immune responses Pickard, Karen M.
2004
38-39 2 p. 271-285
15 p.
artikel
132 Index 1999
38-39 2 p. 365-370
6 p.
artikel
133 Index 2002
38-39 2 p. I1-I3
nvt p.
artikel
134 Index 2000
38-39 2 p. 351-355
5 p.
artikel
135 Index 2001
38-39 2 p. I1-I3
nvt p.
artikel
136 Integration of chemoembolization and radioembolization into multimodal treatment of cholangiocarcinoma Seidensticker, Ricarda
2015
38-39 2 p. 319-332
14 p.
artikel
137 Interaction of Helicobacter pylori infection and low-dose aspirin in the upper gastrointestinal tract: Implications for clinical practice Leung Ki, En-ling
2012
38-39 2 p. 163-172
10 p.
artikel
138 Interactions between dendritic cells and bacteria in the regulation of intestinal immunity Stagg, Andrew J
2004
38-39 2 p. 255-270
16 p.
artikel
139 Interferon-free antiviral therapy for chronic hepatitis C among patients in the liver transplant setting van Tilborg, Marjolein
2017
38-39 2 p. 219-225
7 p.
artikel
140 Intestinal transplantation Rege, Aparna
2016
38-39 2 p. 319-335
17 p.
artikel
141 Intracellular free ionized calcium in the pathogenesis of acute pancreatitis Raraty, Michael G.T.
1999
38-39 2 p. 241-251
11 p.
artikel
142 Introduction to molecular and clinical genetics of colorectal cancer syndromes Tops, Carli M.J.
2009
38-39 2 p. 127-146
20 p.
artikel
143 Invasive and non-invasive methods for the assessment of fibrosis and disease progression in chronic liver disease Castera, Laurent
2011
38-39 2 p. 291-303
13 p.
artikel
144 Irritable bowel syndrome Verdu, Elena F
2004
38-39 2 p. 315-321
7 p.
artikel
145 Letter to the Editor/Case report: Why should we not tube-feed patients with severe Alzheimer dementia? van Bruchem-Visser, Rozemarijn Lidewij
2014
38-39 2 p. 255-256
2 p.
artikel
146 Liver cirrhosis Pinzani, Massimo
2011
38-39 2 p. 281-290
10 p.
artikel
147 Liver failure and liver transplantation Metselaar, Herold J.
2017
38-39 2 p. 127-
1 p.
artikel
148 Liver fibrogenic cells Forbes, Stuart J.
2011
38-39 2 p. 207-217
11 p.
artikel
149 Liver fibrosis in paediatric liver diseases Alisi, Anna
2011
38-39 2 p. 259-268
10 p.
artikel
150 Liver, pancreas and small bowel transplantation: Current ethical issues van Dijk, Gert
2014
38-39 2 p. 281-292
12 p.
artikel
151 Liver transplantation M. Neuberger, James
2003
38-39 2 p. 277-289
13 p.
artikel
152 Liver transplantation for hepatitis C virus related cirrhosis Crosbie, Orla M.
2000
38-39 2 p. 307-325
19 p.
artikel
153 Management of Barrett's oesophagus, dysplasia and early adenocarcinoma Pech, Oliver
2001
38-39 2 p. 267-284
18 p.
artikel
154 Management of lower gastrointestinal tract bleeding Barnert, J.
2008
38-39 2 p. 295-312
18 p.
artikel
155 Mechanisms of hepatic fibrogenesis Lee, Ursula E.
2011
38-39 2 p. 195-206
12 p.
artikel
156 Mechanisms of intestinal adaptation Rubin, Deborah C.
2016
38-39 2 p. 237-248
12 p.
artikel
157 Mechanisms of intracellular zymogen activation Gorelick, Fred S.
1999
38-39 2 p. 227-240
14 p.
artikel
158 Metabolic liver disease in the young adult Mailliard, Mark E.
2003
38-39 2 p. 307-322
16 p.
artikel
159 Microbial perturbations and modulation in conditions associated with malnutrition and malabsorption Jonkers, Daisy M.A.E.
2016
38-39 2 p. 161-172
12 p.
artikel
160 Modification of immunosuppressive therapy as risk factor for complications after liver transplantation De Simone, Paolo
2017
38-39 2 p. 199-209
11 p.
artikel
161 Molecular and cellular biology of pre-malignancy in the gastrointestinal tract Jass, Jeremy R.
2001
38-39 2 p. 175-189
15 p.
artikel
162 Molecular and genetic defects in colorectal tumorigenesis Tejpar, Sabine
2002
38-39 2 p. 171-185
15 p.
artikel
163 Molecular markers in prognosis of colorectal cancer and prediction of response to treatment Pasche, Boris
2002
38-39 2 p. 331-345
15 p.
artikel
164 Molecular pathogenesis of pancreatic cancer Maitra, Anirban
2006
38-39 2 p. 211-226
16 p.
artikel
165 Mucosal immune responses Acheson, David W.K
2004
38-39 2 p. 387-404
18 p.
artikel
166 MUTYH-associated polyposis Sampson, Julian R.
2009
38-39 2 p. 209-218
10 p.
artikel
167 Natural history of acute pancreatitis and the role of infection Isenmann, Rainer
1999
38-39 2 p. 291-301
11 p.
artikel
168 Natural history of HCV infection Poynard, Thierry
2000
38-39 2 p. 211-228
18 p.
artikel
169 New drugs for hepatitis C virus (HCV) Clarke, Berwyn E.
2000
38-39 2 p. 293-305
13 p.
artikel
170 [No title] Ghaneh, Paula
2006
38-39 2 p. 195-
1 p.
artikel
171 Novel approaches: Tissue engineering and stem cells – In vitro modelling of the gut van Rijn, Jorik M.
2016
38-39 2 p. 281-293
13 p.
artikel
172 Obscure gastrointestinal bleeding: Role of videocapsule and double-balloon enteroscopy Cellier, Christophe
2008
38-39 2 p. 329-340
12 p.
artikel
173 Ordinary Tales from Endoscopic Odysseys Meulenberg, Frans
2014
38-39 2 p. 349-359
11 p.
artikel
174 Parenteral approaches in malabsorption: Home parenteral nutrition Wanten, Geert J.A.
2016
38-39 2 p. 309-318
10 p.
artikel
175 Pathogenesis of cholangiocarcinoma: From genetics to signalling pathways Kongpetch, Sarinya
2015
38-39 2 p. 233-244
12 p.
artikel
176 Pathologic classification of cholangiocarcinoma: New concepts Nakanuma, Yasuni
2015
38-39 2 p. 277-293
17 p.
artikel
177 Pharmacogenetics in chemotherapy of colorectal cancer Henriette Tanja, Lieke
2009
38-39 2 p. 257-273
17 p.
artikel
178 Physiology of Intestinal Absorption and Secretion Kiela, Pawel R.
2016
38-39 2 p. 145-159
15 p.
artikel
179 ‘Please, sir, can I have some more?’ Food, lifestyle, diets: Respect and moral responsibility de Beaufort, Inez
2014
38-39 2 p. 235-245
11 p.
artikel
180 Positron emission tomography in colorectal cancer Flamen, Patrick
2002
38-39 2 p. 237-251
15 p.
artikel
181 Potential new endoscopic techniques for the earlier diagnosis of pre-malignancy Rollins, Andrew M
2001
38-39 2 p. 227-247
21 p.
artikel
182 Prebiotics Manning, Thea Scantlebury
2004
38-39 2 p. 287-298
12 p.
artikel
183 Precancerous lesions in inflammatory bowel disease Harpaz, Noam
2013
38-39 2 p. 257-267
11 p.
artikel
184 Precancerous lesions in the stomach: From biology to clinical patient management Rugge, Massimo
2013
38-39 2 p. 205-223
19 p.
artikel
185 Precancerous lesions of the biliary tree Klöppel, Günter
2013
38-39 2 p. 285-297
13 p.
artikel
186 Precancerous lesions of the pancreas Zamboni, Giuseppe
2013
38-39 2 p. 299-322
24 p.
artikel
187 Preface Vasen, Hans F.A.
2009
38-39 2 p. 125-126
2 p.
artikel
188 Preface Thomson, A.B.R.
2003
38-39 2 p. 139-140
2 p.
artikel
189 Preface van Leerdam, M.E.
2008
38-39 2 p. 207-208
2 p.
artikel
190 Preface Farthing, M.J.G.
2004
38-39 2 p. 231-
1 p.
artikel
191 Preface Axon, Anthony
2007
38-39 2 p. 203-204
2 p.
artikel
192 Preface Beglinger, Christoph
2010
38-39 2 p. 89-
1 p.
artikel
193 Preface Gluud, Lise Lotte
2005
38-39 2 p. 175-176
2 p.
artikel
194 Preface Neoptolemos, John P.
1999
38-39 2 p. vii-
1 p.
artikel
195 Preface Cutsem, Eric Van
2002
38-39 2 p. vii-
1 p.
artikel
196 Preface Dijkstra, Gerard
2016
38-39 2 p. 143-144
2 p.
artikel
197 Preface 2000
38-39 2 p. vii-
1 p.
artikel
198 Preface Axon, A.T.R.
2001
38-39 2 p. 7-
1 p.
artikel
199 Prevention of damage induced by aspirin in the GI tract Scheiman, James M.
2012
38-39 2 p. 153-162
10 p.
artikel
200 Probiotics Isolauri, Erika
2004
38-39 2 p. 299-313
15 p.
artikel
201 Progress in enteric vaccine development Svennerholm, Ann-Mari
2004
38-39 2 p. 421-445
25 p.
artikel
202 Promoting intestinal adaptation by nutrition and medication Neelis, E.G.
2016
38-39 2 p. 249-261
13 p.
artikel
203 Prospects for vaccine therapy for pancreatic cancer Gaudernack, Gustav
2006
38-39 2 p. 299-314
16 p.
artikel
204 Psychosocial issues in the child with chronic conditions Geist, Rose
2003
38-39 2 p. 141-152
12 p.
artikel
205 Radiation plus chemotherapy as adjuvant therapy for rectal cancer Minsky, Bruce D.
2002
38-39 2 p. 267-282
16 p.
artikel
206 Radiological diagnosis in cholangiocarcinoma: Application of computed tomography, magnetic resonance imaging, and positron emission tomography Ringe, Kristina I.
2015
38-39 2 p. 253-265
13 p.
artikel
207 Recurrence of primary sclerosing cholangitis, primary biliary cholangitis and auto-immune hepatitis after liver transplantation Visseren, T.
2017
38-39 2 p. 187-198
12 p.
artikel
208 Replication of the hepatitis C virus Bartenschlager, Ralf
2000
38-39 2 p. 241-254
14 p.
artikel
209 Resection and local therapy for liver metastases Schlag, P.M.
2002
38-39 2 p. 299-317
19 p.
artikel
210 RETRACTED: Gastric mucosal defense and cytoprotection Tulassay, Zsolt
2010
38-39 2 p. 99-108
10 p.
artikel
211 Reversal of liver fibrosis: From fiction to reality Zoubek, Miguel Eugenio
2017
38-39 2 p. 129-141
13 p.
artikel
212 Risk factors for gastrointestinal bleeding associated with low-dose aspirin Valkhoff, Vera E.
2012
38-39 2 p. 125-140
16 p.
artikel
213 Role of ASA in the primary and secondary prevention of cardiovascular events Casado-Arroyo, Rubén
2012
38-39 2 p. 113-123
11 p.
artikel
214 Role of ERCP and endoscopic sphincterotomy in acute pancreatitis Nitsche, R.
1999
38-39 2 p. 331-343
13 p.
artikel
215 Role of photodynamic therapy and intraductal radiofrequency ablation in cholangiocarcinoma Patel, Janaki
2015
38-39 2 p. 309-318
10 p.
artikel
216 Role of surgery in cholangiocarcinoma: From resection to transplantation Neumann, Ulf P.
2015
38-39 2 p. 295-308
14 p.
artikel
217 Secondary cancer prevention Rugge, Massimo
2013
38-39 2 p. 157-158
2 p.
artikel
218 Squamous cell cancer of the oesophagus Messmann, Helmut
2001
38-39 2 p. 249-265
17 p.
artikel
219 Surgery for colon and rectal cancer Mitry, Emmanuel
2002
38-39 2 p. 253-265
13 p.
artikel
220 Surgical management and autologous intestinal reconstruction in short bowel syndrome Hommel, Matthijs J.
2016
38-39 2 p. 263-280
18 p.
artikel
221 Surveillance of pre-malignant disease of the pancreatico-biliary system Friess, H.
2001
38-39 2 p. 285-300
16 p.
artikel
222 Systemic therapy of cholangiocarcinoma: From chemotherapy to targeted therapies Schweitzer, N.
2015
38-39 2 p. 345-353
9 p.
artikel
223 The argument for pre-operative chemoradiation for localized, radiographically resectable pancreatic cancer Crane, Christopher H.
2006
38-39 2 p. 365-382
18 p.
artikel
224 The case for adjuvant chemoradiation for pancreatic cancer Garofalo, Michael
2006
38-39 2 p. 403-416
14 p.
artikel
225 The case for adjuvant chemotherapy in pancreatic cancer Ghaneh, Paula
2006
38-39 2 p. 383-401
19 p.
artikel
226 The health economics of Helicobacter pylori infection Moayyedi, Paul
2007
38-39 2 p. 347-361
15 p.
artikel
227 The inflammatory and immune response to Helicobacter pylori infection Robinson, Karen
2007
38-39 2 p. 237-259
23 p.
artikel
228 The inherited genetics of pancreatic cancer and prospects for secondary screening Vitone, Louis J.
2006
38-39 2 p. 253-283
31 p.
artikel
229 The integrity of science – Lost in translation? Kaiser, Matthias
2014
38-39 2 p. 339-347
9 p.
artikel
230 The pathology of epithelial pre-malignancy of the gastrointestinal tract Guindi, Maha
2001
38-39 2 p. 191-210
20 p.
artikel
231 The possible role of platelet-activating factor antagonist therapy in the management of severe acute pancreatitis Imrie, C.W.
1999
38-39 2 p. 357-364
8 p.
artikel
232 Therapeutic options for endoscopic haemostatic failures: the place of the surgeon and radiologist in gastrointestinal tract bleeding Busch, Olivier R.C.
2008
38-39 2 p. 341-354
14 p.
artikel
233 Therapeutic options for HCV—management of the infected individual Foster, G.R
2000
38-39 2 p. 255-264
10 p.
artikel
234 The recognition and endoscopic treatment of early gastric and colonic cancer Rembacken, Bjorn
2001
38-39 2 p. 317-336
20 p.
artikel
235 The role of adjuvant chemotherapy and radiotherapy for cholangiocarcinoma Howell, Matthew
2015
38-39 2 p. 333-343
11 p.
artikel
236 The role of blood transfusion in the management of upper and lower intestinal tract bleeding Hearnshaw, Sarah
2008
38-39 2 p. 355-371
17 p.
artikel
237 The role of nutrition and chemoprevention in colorectal cancer: from observations to expectations Vaisman, Nachum
2002
38-39 2 p. 201-217
17 p.
artikel
238 The transmission of Helicobacter pylori: The effects of analysis method and study population on inference Delport, Wayne
2007
38-39 2 p. 215-236
22 p.
artikel
239 The treatment of advanced colorectal cancer: where are we now and where do we go? Cutsem, Eric Van
2002
38-39 2 p. 319-330
12 p.
artikel
240 The use of old donors in liver transplantation Dasari, Bobby V.M.
2017
38-39 2 p. 211-217
7 p.
artikel
241 Transitioning the paediatric IBD patient to adult care Désir, Barbara
2003
38-39 2 p. 197-212
16 p.
artikel
242 Treatment of chronic hepatitis C virus infection in children Chang, Mei-Hwei
2000
38-39 2 p. 341-350
10 p.
artikel
243 Treatment of Helicobacter pylori Wolle, K.
2007
38-39 2 p. 315-324
10 p.
artikel
244 Unusual causes of abdominal pain: sickle cell anemia Ahmed, Shahid
2005
38-39 2 p. 297-310
14 p.
artikel
245 Update on genetics in inflammatory disease Noomen, Casper G.
2009
38-39 2 p. 233-243
11 p.
artikel
246 Usefulness of prognostic indices in upper gastrointestinal bleeding Atkinson, Robert James
2008
38-39 2 p. 233-242
10 p.
artikel
247 Vascular lesions of the gastrointestinal tract Regula, Jaroslaw
2008
38-39 2 p. 313-328
16 p.
artikel
248 Vasculitis in the gastrointestinal tract Morgan, Matthew D.
2005
38-39 2 p. 215-233
19 p.
artikel
249 Venous resection in pancreatic cancer surgery Tseng, Jennifer F.
2006
38-39 2 p. 349-364
16 p.
artikel
250 Virtual colonoscopy Smith, Clare S.
2002
38-39 2 p. 219-236
18 p.
artikel
251 What's new in pancreatic cancer treatment pipeline? Von Hoff, Daniel D.
2006
38-39 2 p. 315-326
12 p.
artikel
                             251 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland